Serina Therapeutics, Inc.
SER
Rank in Stocks
#26230
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Share Price
$1.43
Last synced: 2026-11-09
Market Cap
$21.45M
Change (1 day)
3.62%
Change (1 year)
-64.95%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Serina Therapeutics, Inc. (SER)
Category
Healthcare
EPS for Serina Therapeutics, Inc. (SER)
EPS as of June 2026 TTM: $-1.88
According to Serina Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-1.88. At the end of 2025 the company had an EPS of $-1.91, a decrease compared to its 2024 EPS of $-1.51.
EPS history for Serina Therapeutics, Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.88 | -1.57% |
| 2025 | $-1.91 | 26.49% |
| 2024 | $-1.51 | -339.68% |
| 2023 | $0.63 | -125.30% |
| 2022 | $-2.49 | 322.03% |
| 2021 | $-0.59 | -94.18% |
| 2020 | $-10.14 | -11.60% |
| 2019 | $-11.47 | 51.72% |
| 2018 | $-7.56 | 17.03% |
| 2017 | $-6.46 | -57.53% |
| 2016 | $-15.21 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -932.98% |
US
|
|
| $-7.07 | 276.06% |
US
|
|
| $-5.29 | 181.38% |
AU
|
|
| $12.88 | -785.11% |
BE
|
|
| $21.56 | -1,246.81% |
NL
|
Questions about Serina Therapeutics, Inc.'s earnings per share (EPS)
What is Serina Therapeutics, Inc.'s earnings per share (EPS)?
Serina Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-1.88, as of Jun 2026.
What was Serina Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Serina Therapeutics, Inc.'s earnings per share (EPS) was $-1.91, compared with $-1.51 in 2024.
How has Serina Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Serina Therapeutics, Inc.'s earnings per share (EPS) was highest in 2023 ($0.63) and lowest in 2020 ($-10.14).
How does Serina Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Serina Therapeutics, Inc.'s earnings per share (EPS) ($-1.88) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.